Supplement Adverse Event Portal Should Speed Signals Of Problems
This article was originally published in The Tan Sheet
Executive Summary
FDA hopes the portal will spur “enhanced submission of AERs” and allow agency officials to determine more rapidly whether causal links exist between a product or ingredient and adverse events, says supplement programs chief Daniel Fabricant.
You may also be interested in...
Final Guidance For Reporting Adverse Events Gets Serious On Definitions
A report of emergency room treatment connected to use of a dietary supplement may not connote a serious adverse event, FDA says in the final guidance on the reporting and recordkeeping of AE information for supplements
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.